1 / 12

HIV Vaccine Clinical Trials

HIV Vaccine Clinical Trials. The need for community involvement. My involvement in vaccines. I am currently working for Imperial College at St. Mary’s Hospital, London as HIV Research Manager At the Clinical Trials Centre we have completed 3 HIV vaccine trials and about to recruit to 4 th

parker
Download Presentation

HIV Vaccine Clinical Trials

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. HIV Vaccine Clinical Trials The need for community involvement

  2. My involvement in vaccines • I am currently working for Imperial College at St. Mary’s Hospital, London as HIV Research Manager • At the Clinical Trials Centre we have completed 3 HIV vaccine trials and about to recruit to 4th • All trials so far have been in low-risk healthy volunteers • At some point in the future we hope to carry-out some large scale, “high risk” group trials

  3. What is the community? • What do we mean by the community? • General population? • Local population? • The elected governments? • Non governmental organisations? • HIV positive groups? • HIV positive individuals? • At risk HIV negative population, groups and individuals?

  4. The Community in Phase I trials • All are involved in some way in the development of an HIV vaccine • The government must be involved by funding/promoting HIV vaccine development • The general population/individuals are involved by volunteering for trials • The NGOs must be involved by reviewing the trials and publicising them • HIV infected individuals and high risk groups currently are the least involved

  5. Community involvement in past vaccine trials • Community involvement has nearly all been through the HIV NGOs • their involvement has increased with each new trial. • They have the knowledge to assess the validity of the work. • Their endorsement gives the trials credibility within the HIV community. • Promoting the vaccine trials within the HIV community and the media helps with recruitment.

  6. NGO involvement • On a recent vaccine trial 10% of volunteers were recruited through HIV newsletters and 20% via e-mails sent around staff at NGOs • NGOs have given advice to possible volunteers about participating in an HIV vaccine trial • Representatives from NGOs & patient groups have attended pre-launch meetings for vaccine trials

  7. Phase III HIV vaccine trials • Phase III trials assess the efficacy and safety in large numbers of “high risk” population • Phase III vaccine trials will need to recruit between 3,000 and 15,000 people to be statistically powered to prove the vaccine is able to prevent HIV infection • In order to recruit this many volunteers many months of preparation work and promotion will be needed whether the trials are in the UK or worldwide

  8. AIDSVAX trials • Only two Phase III HIV vaccine trials have been completed • Results from both were reported earlier this year • The first was in 5000 gay men and 400 women and was conducted in the USA, Canada, Puerto Rico and the Netherlands • The second in 2500 injecting drug users in Thailand • Neither trial was able to show that the vaccine prevented HIV infection

  9. Future plans • As part of the preparation for future phase III trials we will set up a Community Advisory Board. • Information from the CAB will help develop trial strategies • The board will include representatives from the local community, gay community, members of NGOs, public health officials and people living with HIV • Main target group for the trials will probably be the gay community

  10. What need to be done? • Further development of our collaborations with the NGOs. • Carry out some social research with them which can be developed at the same time as the trial protocols • Introduce a participant advisory group to learn from the people who have actually taken part in a trial

  11. Thoughts for future trials • Are there any other ways we can increase the input of the HIV community and at risk groups in the planning and promotion of future phase I/II & phase III trials? • Is it really necessary if there may never be a phase III trial in the UK? • And finally…….

  12. Advertisement • We need healthy volunteers for EUROVAC II a phase I trial of an HIV vaccine. • If you would like to help please call Miranda Cowen at the Clinical Trials Centre, St. Mary’s Hospital, Paddington on free-phone 0800 587 4406 • Thank you

More Related